RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation.
Identifieur interne : 001138 ( PubMed/Corpus ); précédent : 001137; suivant : 001139RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation.
Auteurs : Jane A C. Wilson ; Natalie A. Prow ; Wayne A. Schroder ; Jonathan J. Ellis ; Helen E. Cumming ; Linden J. Gearing ; Yee Suan Poo ; Adam Taylor ; Paul J. Hertzog ; Francesca Di Giallonardo ; Linda Hueston ; Roger Le Grand ; Bing Tang ; Thuy T. Le ; Joy Gardner ; Suresh Mahalingam ; Pierre Roques ; Phillip I. Bird ; Andreas SuhrbierSource :
- PLoS pathogens [ 1553-7374 ] ; 2017.
English descriptors
- KwdEn :
- Animals, Arthritis (virology), Chikungunya Fever (genetics), Chikungunya Fever (immunology), Chikungunya virus, Disease Models, Animal, Granzymes (analysis), Granzymes (biosynthesis), Granzymes (immunology), Humans, Immunohistochemistry, Inflammation (virology), Macaca fascicularis, Mice, Mice, Inbred C57BL, Mice, Knockout, RNA, Messenger (analysis), Transcriptome.
- MESH :
- chemical , analysis : Granzymes, RNA, Messenger.
- chemical , biosynthesis : Granzymes.
- genetics : Chikungunya Fever.
- immunology : Chikungunya Fever, Granzymes.
- virology : Arthritis, Inflammation.
- Animals, Chikungunya virus, Disease Models, Animal, Humans, Immunohistochemistry, Macaca fascicularis, Mice, Mice, Inbred C57BL, Mice, Knockout, Transcriptome.
Abstract
Chikungunya virus (CHIKV) is an arthritogenic alphavirus causing epidemics of acute and chronic arthritic disease. Herein we describe a comprehensive RNA-Seq analysis of feet and lymph nodes at peak viraemia (day 2 post infection), acute arthritis (day 7) and chronic disease (day 30) in the CHIKV adult wild-type mouse model. Genes previously shown to be up-regulated in CHIKV patients were also up-regulated in the mouse model. CHIKV sequence information was also obtained with up to ≈8% of the reads mapping to the viral genome; however, no adaptive viral genome changes were apparent. Although day 2, 7 and 30 represent distinct stages of infection and disease, there was a pronounced overlap in up-regulated host genes and pathways. Type I interferon response genes (IRGs) represented up to ≈50% of up-regulated genes, even after loss of type I interferon induction on days 7 and 30. Bioinformatic analyses suggested a number of interferon response factors were primarily responsible for maintaining type I IRG induction. A group of genes prominent in the RNA-Seq analysis and hitherto unexplored in viral arthropathies were granzymes A, B and K. Granzyme A-/- and to a lesser extent granzyme K-/-, but not granzyme B-/-, mice showed a pronounced reduction in foot swelling and arthritis, with analysis of granzyme A-/- mice showing no reductions in viral loads but reduced NK and T cell infiltrates post CHIKV infection. Treatment with Serpinb6b, a granzyme A inhibitor, also reduced arthritic inflammation in wild-type mice. In non-human primates circulating granzyme A levels were elevated after CHIKV infection, with the increase correlating with viral load. Elevated granzyme A levels were also seen in a small cohort of human CHIKV patients. Taken together these results suggest granzyme A is an important driver of arthritic inflammation and a potential target for therapy.
DOI: 10.1371/journal.ppat.1006155
PubMed: 28207896
Links to Exploration step
pubmed:28207896Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation.</title>
<author><name sortKey="Wilson, Jane A C" sort="Wilson, Jane A C" uniqKey="Wilson J" first="Jane A C" last="Wilson">Jane A C. Wilson</name>
<affiliation><nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Prow, Natalie A" sort="Prow, Natalie A" uniqKey="Prow N" first="Natalie A" last="Prow">Natalie A. Prow</name>
<affiliation><nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Schroder, Wayne A" sort="Schroder, Wayne A" uniqKey="Schroder W" first="Wayne A" last="Schroder">Wayne A. Schroder</name>
<affiliation><nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ellis, Jonathan J" sort="Ellis, Jonathan J" uniqKey="Ellis J" first="Jonathan J" last="Ellis">Jonathan J. Ellis</name>
<affiliation><nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cumming, Helen E" sort="Cumming, Helen E" uniqKey="Cumming H" first="Helen E" last="Cumming">Helen E. Cumming</name>
<affiliation><nlm:affiliation>Hudson Institute of Medical Research, Clayton, Victoria, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gearing, Linden J" sort="Gearing, Linden J" uniqKey="Gearing L" first="Linden J" last="Gearing">Linden J. Gearing</name>
<affiliation><nlm:affiliation>Hudson Institute of Medical Research, Clayton, Victoria, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Poo, Yee Suan" sort="Poo, Yee Suan" uniqKey="Poo Y" first="Yee Suan" last="Poo">Yee Suan Poo</name>
<affiliation><nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Taylor, Adam" sort="Taylor, Adam" uniqKey="Taylor A" first="Adam" last="Taylor">Adam Taylor</name>
<affiliation><nlm:affiliation>Institute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hertzog, Paul J" sort="Hertzog, Paul J" uniqKey="Hertzog P" first="Paul J" last="Hertzog">Paul J. Hertzog</name>
<affiliation><nlm:affiliation>Hudson Institute of Medical Research, Clayton, Victoria, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Di Giallonardo, Francesca" sort="Di Giallonardo, Francesca" uniqKey="Di Giallonardo F" first="Francesca" last="Di Giallonardo">Francesca Di Giallonardo</name>
<affiliation><nlm:affiliation>Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hueston, Linda" sort="Hueston, Linda" uniqKey="Hueston L" first="Linda" last="Hueston">Linda Hueston</name>
<affiliation><nlm:affiliation>Centre for Infectious Diseases and Microbiology Laboratory Services, Westmead Hospital, Sydney, NSW, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Le Grand, Roger" sort="Le Grand, Roger" uniqKey="Le Grand R" first="Roger" last="Le Grand">Roger Le Grand</name>
<affiliation><nlm:affiliation>CEA, Inserm, Université Paris Sud; iMETI; UMR 1184 Immunology of Viral infections and Autoimmune diseases, Fontenay-aux-Roses, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tang, Bing" sort="Tang, Bing" uniqKey="Tang B" first="Bing" last="Tang">Bing Tang</name>
<affiliation><nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Le, Thuy T" sort="Le, Thuy T" uniqKey="Le T" first="Thuy T" last="Le">Thuy T. Le</name>
<affiliation><nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gardner, Joy" sort="Gardner, Joy" uniqKey="Gardner J" first="Joy" last="Gardner">Joy Gardner</name>
<affiliation><nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mahalingam, Suresh" sort="Mahalingam, Suresh" uniqKey="Mahalingam S" first="Suresh" last="Mahalingam">Suresh Mahalingam</name>
<affiliation><nlm:affiliation>Institute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Roques, Pierre" sort="Roques, Pierre" uniqKey="Roques P" first="Pierre" last="Roques">Pierre Roques</name>
<affiliation><nlm:affiliation>CEA, Inserm, Université Paris Sud; iMETI; UMR 1184 Immunology of Viral infections and Autoimmune diseases, Fontenay-aux-Roses, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bird, Phillip I" sort="Bird, Phillip I" uniqKey="Bird P" first="Phillip I" last="Bird">Phillip I. Bird</name>
<affiliation><nlm:affiliation>Biomedicine Discovery Institute, Monash University, Victoria 3800, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Suhrbier, Andreas" sort="Suhrbier, Andreas" uniqKey="Suhrbier A" first="Andreas" last="Suhrbier">Andreas Suhrbier</name>
<affiliation><nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28207896</idno>
<idno type="pmid">28207896</idno>
<idno type="doi">10.1371/journal.ppat.1006155</idno>
<idno type="wicri:Area/PubMed/Corpus">001138</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001138</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation.</title>
<author><name sortKey="Wilson, Jane A C" sort="Wilson, Jane A C" uniqKey="Wilson J" first="Jane A C" last="Wilson">Jane A C. Wilson</name>
<affiliation><nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Prow, Natalie A" sort="Prow, Natalie A" uniqKey="Prow N" first="Natalie A" last="Prow">Natalie A. Prow</name>
<affiliation><nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Schroder, Wayne A" sort="Schroder, Wayne A" uniqKey="Schroder W" first="Wayne A" last="Schroder">Wayne A. Schroder</name>
<affiliation><nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ellis, Jonathan J" sort="Ellis, Jonathan J" uniqKey="Ellis J" first="Jonathan J" last="Ellis">Jonathan J. Ellis</name>
<affiliation><nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Cumming, Helen E" sort="Cumming, Helen E" uniqKey="Cumming H" first="Helen E" last="Cumming">Helen E. Cumming</name>
<affiliation><nlm:affiliation>Hudson Institute of Medical Research, Clayton, Victoria, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gearing, Linden J" sort="Gearing, Linden J" uniqKey="Gearing L" first="Linden J" last="Gearing">Linden J. Gearing</name>
<affiliation><nlm:affiliation>Hudson Institute of Medical Research, Clayton, Victoria, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Poo, Yee Suan" sort="Poo, Yee Suan" uniqKey="Poo Y" first="Yee Suan" last="Poo">Yee Suan Poo</name>
<affiliation><nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Taylor, Adam" sort="Taylor, Adam" uniqKey="Taylor A" first="Adam" last="Taylor">Adam Taylor</name>
<affiliation><nlm:affiliation>Institute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hertzog, Paul J" sort="Hertzog, Paul J" uniqKey="Hertzog P" first="Paul J" last="Hertzog">Paul J. Hertzog</name>
<affiliation><nlm:affiliation>Hudson Institute of Medical Research, Clayton, Victoria, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Di Giallonardo, Francesca" sort="Di Giallonardo, Francesca" uniqKey="Di Giallonardo F" first="Francesca" last="Di Giallonardo">Francesca Di Giallonardo</name>
<affiliation><nlm:affiliation>Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Hueston, Linda" sort="Hueston, Linda" uniqKey="Hueston L" first="Linda" last="Hueston">Linda Hueston</name>
<affiliation><nlm:affiliation>Centre for Infectious Diseases and Microbiology Laboratory Services, Westmead Hospital, Sydney, NSW, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Le Grand, Roger" sort="Le Grand, Roger" uniqKey="Le Grand R" first="Roger" last="Le Grand">Roger Le Grand</name>
<affiliation><nlm:affiliation>CEA, Inserm, Université Paris Sud; iMETI; UMR 1184 Immunology of Viral infections and Autoimmune diseases, Fontenay-aux-Roses, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Tang, Bing" sort="Tang, Bing" uniqKey="Tang B" first="Bing" last="Tang">Bing Tang</name>
<affiliation><nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Le, Thuy T" sort="Le, Thuy T" uniqKey="Le T" first="Thuy T" last="Le">Thuy T. Le</name>
<affiliation><nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Gardner, Joy" sort="Gardner, Joy" uniqKey="Gardner J" first="Joy" last="Gardner">Joy Gardner</name>
<affiliation><nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mahalingam, Suresh" sort="Mahalingam, Suresh" uniqKey="Mahalingam S" first="Suresh" last="Mahalingam">Suresh Mahalingam</name>
<affiliation><nlm:affiliation>Institute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Roques, Pierre" sort="Roques, Pierre" uniqKey="Roques P" first="Pierre" last="Roques">Pierre Roques</name>
<affiliation><nlm:affiliation>CEA, Inserm, Université Paris Sud; iMETI; UMR 1184 Immunology of Viral infections and Autoimmune diseases, Fontenay-aux-Roses, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bird, Phillip I" sort="Bird, Phillip I" uniqKey="Bird P" first="Phillip I" last="Bird">Phillip I. Bird</name>
<affiliation><nlm:affiliation>Biomedicine Discovery Institute, Monash University, Victoria 3800, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Suhrbier, Andreas" sort="Suhrbier, Andreas" uniqKey="Suhrbier A" first="Andreas" last="Suhrbier">Andreas Suhrbier</name>
<affiliation><nlm:affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">PLoS pathogens</title>
<idno type="eISSN">1553-7374</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Arthritis (virology)</term>
<term>Chikungunya Fever (genetics)</term>
<term>Chikungunya Fever (immunology)</term>
<term>Chikungunya virus</term>
<term>Disease Models, Animal</term>
<term>Granzymes (analysis)</term>
<term>Granzymes (biosynthesis)</term>
<term>Granzymes (immunology)</term>
<term>Humans</term>
<term>Immunohistochemistry</term>
<term>Inflammation (virology)</term>
<term>Macaca fascicularis</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Mice, Knockout</term>
<term>RNA, Messenger (analysis)</term>
<term>Transcriptome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en"><term>Granzymes</term>
<term>RNA, Messenger</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Granzymes</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Chikungunya Fever</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Chikungunya Fever</term>
<term>Granzymes</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Arthritis</term>
<term>Inflammation</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Chikungunya virus</term>
<term>Disease Models, Animal</term>
<term>Humans</term>
<term>Immunohistochemistry</term>
<term>Macaca fascicularis</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>Mice, Knockout</term>
<term>Transcriptome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Chikungunya virus (CHIKV) is an arthritogenic alphavirus causing epidemics of acute and chronic arthritic disease. Herein we describe a comprehensive RNA-Seq analysis of feet and lymph nodes at peak viraemia (day 2 post infection), acute arthritis (day 7) and chronic disease (day 30) in the CHIKV adult wild-type mouse model. Genes previously shown to be up-regulated in CHIKV patients were also up-regulated in the mouse model. CHIKV sequence information was also obtained with up to ≈8% of the reads mapping to the viral genome; however, no adaptive viral genome changes were apparent. Although day 2, 7 and 30 represent distinct stages of infection and disease, there was a pronounced overlap in up-regulated host genes and pathways. Type I interferon response genes (IRGs) represented up to ≈50% of up-regulated genes, even after loss of type I interferon induction on days 7 and 30. Bioinformatic analyses suggested a number of interferon response factors were primarily responsible for maintaining type I IRG induction. A group of genes prominent in the RNA-Seq analysis and hitherto unexplored in viral arthropathies were granzymes A, B and K. Granzyme A-/- and to a lesser extent granzyme K-/-, but not granzyme B-/-, mice showed a pronounced reduction in foot swelling and arthritis, with analysis of granzyme A-/- mice showing no reductions in viral loads but reduced NK and T cell infiltrates post CHIKV infection. Treatment with Serpinb6b, a granzyme A inhibitor, also reduced arthritic inflammation in wild-type mice. In non-human primates circulating granzyme A levels were elevated after CHIKV infection, with the increase correlating with viral load. Elevated granzyme A levels were also seen in a small cohort of human CHIKV patients. Taken together these results suggest granzyme A is an important driver of arthritic inflammation and a potential target for therapy.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28207896</PMID>
<DateCreated><Year>2017</Year>
<Month>02</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>08</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>08</Month>
<Day>03</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>13</Volume>
<Issue>2</Issue>
<PubDate><Year>2017</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>PLoS pathogens</Title>
<ISOAbbreviation>PLoS Pathog.</ISOAbbreviation>
</Journal>
<ArticleTitle>RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation.</ArticleTitle>
<Pagination><MedlinePgn>e1006155</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1006155</ELocationID>
<Abstract><AbstractText>Chikungunya virus (CHIKV) is an arthritogenic alphavirus causing epidemics of acute and chronic arthritic disease. Herein we describe a comprehensive RNA-Seq analysis of feet and lymph nodes at peak viraemia (day 2 post infection), acute arthritis (day 7) and chronic disease (day 30) in the CHIKV adult wild-type mouse model. Genes previously shown to be up-regulated in CHIKV patients were also up-regulated in the mouse model. CHIKV sequence information was also obtained with up to ≈8% of the reads mapping to the viral genome; however, no adaptive viral genome changes were apparent. Although day 2, 7 and 30 represent distinct stages of infection and disease, there was a pronounced overlap in up-regulated host genes and pathways. Type I interferon response genes (IRGs) represented up to ≈50% of up-regulated genes, even after loss of type I interferon induction on days 7 and 30. Bioinformatic analyses suggested a number of interferon response factors were primarily responsible for maintaining type I IRG induction. A group of genes prominent in the RNA-Seq analysis and hitherto unexplored in viral arthropathies were granzymes A, B and K. Granzyme A-/- and to a lesser extent granzyme K-/-, but not granzyme B-/-, mice showed a pronounced reduction in foot swelling and arthritis, with analysis of granzyme A-/- mice showing no reductions in viral loads but reduced NK and T cell infiltrates post CHIKV infection. Treatment with Serpinb6b, a granzyme A inhibitor, also reduced arthritic inflammation in wild-type mice. In non-human primates circulating granzyme A levels were elevated after CHIKV infection, with the increase correlating with viral load. Elevated granzyme A levels were also seen in a small cohort of human CHIKV patients. Taken together these results suggest granzyme A is an important driver of arthritic inflammation and a potential target for therapy.</AbstractText>
<AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov NCT00281294.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wilson</LastName>
<ForeName>Jane A C</ForeName>
<Initials>JA</Initials>
<AffiliationInfo><Affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Australian Infectious Disease Research Centre, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Prow</LastName>
<ForeName>Natalie A</ForeName>
<Initials>NA</Initials>
<AffiliationInfo><Affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Schroder</LastName>
<ForeName>Wayne A</ForeName>
<Initials>WA</Initials>
<AffiliationInfo><Affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ellis</LastName>
<ForeName>Jonathan J</ForeName>
<Initials>JJ</Initials>
<AffiliationInfo><Affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cumming</LastName>
<ForeName>Helen E</ForeName>
<Initials>HE</Initials>
<AffiliationInfo><Affiliation>Hudson Institute of Medical Research, Clayton, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gearing</LastName>
<ForeName>Linden J</ForeName>
<Initials>LJ</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0003-3508-3056</Identifier>
<AffiliationInfo><Affiliation>Hudson Institute of Medical Research, Clayton, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Poo</LastName>
<ForeName>Yee Suan</ForeName>
<Initials>YS</Initials>
<AffiliationInfo><Affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Australian Infectious Disease Research Centre, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Taylor</LastName>
<ForeName>Adam</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-7159-3961</Identifier>
<AffiliationInfo><Affiliation>Institute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hertzog</LastName>
<ForeName>Paul J</ForeName>
<Initials>PJ</Initials>
<AffiliationInfo><Affiliation>Hudson Institute of Medical Research, Clayton, Victoria, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Di Giallonardo</LastName>
<ForeName>Francesca</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Charles Perkins Centre, The University of Sydney, Sydney, NSW, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hueston</LastName>
<ForeName>Linda</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Centre for Infectious Diseases and Microbiology Laboratory Services, Westmead Hospital, Sydney, NSW, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Le Grand</LastName>
<ForeName>Roger</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>CEA, Inserm, Université Paris Sud; iMETI; UMR 1184 Immunology of Viral infections and Autoimmune diseases, Fontenay-aux-Roses, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tang</LastName>
<ForeName>Bing</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Le</LastName>
<ForeName>Thuy T</ForeName>
<Initials>TT</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-9134-0104</Identifier>
<AffiliationInfo><Affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gardner</LastName>
<ForeName>Joy</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mahalingam</LastName>
<ForeName>Suresh</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Institute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Roques</LastName>
<ForeName>Pierre</ForeName>
<Initials>P</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0003-1825-1054</Identifier>
<AffiliationInfo><Affiliation>CEA, Inserm, Université Paris Sud; iMETI; UMR 1184 Immunology of Viral infections and Autoimmune diseases, Fontenay-aux-Roses, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bird</LastName>
<ForeName>Phillip I</ForeName>
<Initials>PI</Initials>
<AffiliationInfo><Affiliation>Biomedicine Discovery Institute, Monash University, Victoria 3800, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Suhrbier</LastName>
<ForeName>Andreas</ForeName>
<Initials>A</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-8986-9025</Identifier>
<AffiliationInfo><Affiliation>QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Australian Infectious Disease Research Centre, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2017</Year>
<Month>02</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>PLoS Pathog</MedlineTA>
<NlmUniqueID>101238921</NlmUniqueID>
<ISSNLinking>1553-7366</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.21.-</RegistryNumber>
<NameOfSubstance UI="D053804">Granzymes</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Lancet Infect Dis. 2015 May;15(5):519-27</RefSource>
<PMID Version="1">25739878</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Immunity. 2014 Dec 18;41(6):960-72</RefSource>
<PMID Version="1">25526309</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2014 Mar 28;289(13):9408-17</RefSource>
<PMID Version="1">24505135</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2010 Feb 15;207(2):429-42</RefSource>
<PMID Version="1">20123960</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Transplant Proc. 1998 Dec;30(8):3972-4</RefSource>
<PMID Version="1">9865265</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Virol. 2014 Nov;88(22):13333-43</RefSource>
<PMID Version="1">25210177</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2010 Jul;38(12):e131</RefSource>
<PMID Version="1">20395217</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2014 Nov 6;9(3):910-7</RefSource>
<PMID Version="1">25437548</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2015 Dec 08;11(12):e1005324</RefSource>
<PMID Version="1">26646986</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arthritis Rheum. 2011 Feb;63(2):488-91</RefSource>
<PMID Version="1">21280003</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arthritis Rheum. 2012 Nov;64(11):3553-63</RefSource>
<PMID Version="1">22833339</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pharmacol Rev. 2016 Oct;68(4):1110-1142</RefSource>
<PMID Version="1">27677721</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Asian Pac J Trop Med. 2013 Aug;6(8):631-4</RefSource>
<PMID Version="1">23790334</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Interferon Res. 1990 Jun;10(3):293-8</RefSource>
<PMID Version="1">1696607</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5117-22</RefSource>
<PMID Version="1">25848017</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Dec 23;8(12):e84695</RefSource>
<PMID Version="1">24376836</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Med. 2015 Apr 30;13:102</RefSource>
<PMID Version="1">25976325</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Microbiol. 2016 Feb;18(2):168-80</RefSource>
<PMID Version="1">26572694</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2012 Jun 15;28(12):1647-9</RefSource>
<PMID Version="1">22543367</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Oct 24;8(10):e76412</RefSource>
<PMID Version="1">24204622</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2011 Feb 15;186(4):2472-81</RefSource>
<PMID Version="1">21248253</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Vaccine. 2011 Mar 24;29(15):2803-9</RefSource>
<PMID Version="1">21320541</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2008 Apr;9(4):378-87</RefSource>
<PMID Version="1">18345002</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Commun. 2016 Feb 19;7:10680</RefSource>
<PMID Version="1">26893169</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pharmacol Ther. 2004 Sep;103(3):245-59</RefSource>
<PMID Version="1">15464592</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2015 Apr 30;11(4):e1004863</RefSource>
<PMID Version="1">25927359</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2014 Nov 1;193(9):4634-42</RefSource>
<PMID Version="1">25261479</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Virol. 2008 Nov;82(22):11263-72</RefSource>
<PMID Version="1">18787004</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Blood. 2015 Aug 20;126(8):e1-e10</RefSource>
<PMID Version="1">26124495</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Immunol. 2013 Dec;149(3):487-97</RefSource>
<PMID Version="1">24239837</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5783-7</RefSource>
<PMID Version="1">8650169</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Virol. 2015 Jan;89(1):581-93</RefSource>
<PMID Version="1">25339772</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Bioinformatics. 2009 May 1;25(9):1105-11</RefSource>
<PMID Version="1">19289445</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Virol. 2014 Mar;88(6):3527-47</RefSource>
<PMID Version="1">24403588</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1999 Jul 16;274(29):20178-84</RefSource>
<PMID Version="1">10400633</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Immunol. 1995 Dec;25(12):3256-62</RefSource>
<PMID Version="1">8566009</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Virol. 1998 Jun;72(6):5146-53</RefSource>
<PMID Version="1">9573286</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2015 May 07;9(5):e0003764</RefSource>
<PMID Version="1">25951202</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Viral Immunol. 2011 Aug;24(4):265-71</RefSource>
<PMID Version="1">21830898</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 1996 Apr 1;156(7):2585-90</RefSource>
<PMID Version="1">8786323</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Trop Med Rep. 2015 Mar;2(1):13-21</RefSource>
<PMID Version="1">26366337</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2015 Jun 15;211(12):1925-35</RefSource>
<PMID Version="1">25635123</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Biomed Res Int. 2013;2013:973516</RefSource>
<PMID Version="1">24069610</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Virology. 2012 Apr 10;425(2):103-12</RefSource>
<PMID Version="1">22305131</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Rev Rheumatol. 2012 May 08;8(7):420-9</RefSource>
<PMID Version="1">22565316</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2000 Jul;182(1):206-13</RefSource>
<PMID Version="1">10882599</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2009 Jan;37(1):1-13</RefSource>
<PMID Version="1">19033363</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Biotechnol. 2010 May;28(5):511-5</RefSource>
<PMID Version="1">20436464</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Brief Bioinform. 2013 Mar;14(2):178-92</RefSource>
<PMID Version="1">22517427</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Virol. 2011 Sep;85(17):8709-17</RefSource>
<PMID Version="1">21715498</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2013 Jan;14(1):61-71</RefSource>
<PMID Version="1">23160154</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Virol. 2009 Apr;83(8):3429-35</RefSource>
<PMID Version="1">19176616</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2010 Aug 1;185(3):1794-803</RefSource>
<PMID Version="1">20585036</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2015 Mar 26;372(13):1231-9</RefSource>
<PMID Version="1">25806915</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Virol. 2010 Aug;84(16):8021-32</RefSource>
<PMID Version="1">20519386</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Immunity. 2007 Aug;27(2):240-52</RefSource>
<PMID Version="1">17723216</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2009;4(1):e4261</RefSource>
<PMID Version="1">19156204</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur J Immunol. 2005 Oct;35(10):2940-8</RefSource>
<PMID Version="1">16208762</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2010 May 15;184(10):5914-27</RefSource>
<PMID Version="1">20404278</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16038-43</RefSource>
<PMID Version="1">21896755</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2013 Jan;9(1):e1003118</RefSource>
<PMID Version="1">23300459</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2000 Oct 1;165(7):3966-9</RefSource>
<PMID Version="1">11034405</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Microbiol Immunol. 2012 Feb;56(2):134-8</RefSource>
<PMID Version="1">22188545</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Biosci. 2015 Apr 18;5:17</RefSource>
<PMID Version="1">25960866</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Virol. 2000 Jan;74(2):1029-32</RefSource>
<PMID Version="1">10623769</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>EMBO J. 2013 Oct 16;32(20):2751-63</RefSource>
<PMID Version="1">24065129</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Virol. 2014 Apr;88(8):4180-94</RefSource>
<PMID Version="1">24478443</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>EMBO Mol Med. 2012 Apr;4(4):330-43</RefSource>
<PMID Version="1">22389221</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol Res. 2015;2015:272359</RefSource>
<PMID Version="1">26199948</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2423</RefSource>
<PMID Version="1">24069479</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Virol. 2014 Jun;88(12):6862-72</RefSource>
<PMID Version="1">24696480</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2015 Feb 19;11(2):e1004649</RefSource>
<PMID Version="1">25695775</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2011 Jul 1;204(1):115-23</RefSource>
<PMID Version="1">21628665</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2013 Jan;41(Database issue):D1040-6</RefSource>
<PMID Version="1">23203888</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Virol. 2015 Oct 14;90(1):92-102</RefSource>
<PMID Version="1">26468529</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2013 Jan 1;190(1):259-69</RefSource>
<PMID Version="1">23209328</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pharmacol Ther. 2009 Dec;124(3):301-8</RefSource>
<PMID Version="1">19788897</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>FEBS J. 2016 May;283(9):1734-47</RefSource>
<PMID Version="1">26936634</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Biochim Biophys Acta. 1995 Sep 27;1252(1):28-34</RefSource>
<PMID Version="1">7548163</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Med Mal Infect. 2015 Jul;45(7):243-63</RefSource>
<PMID Version="1">26119684</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Exp Immunol. 2003 Jun;132(3):467-72</RefSource>
<PMID Version="1">12780694</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Immunity. 2008 Nov 14;29(5):720-33</RefSource>
<PMID Version="1">18951048</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Blood. 2011 Jul 14;118(2):298-308</RefSource>
<PMID Version="1">21411754</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2015 Feb;15(2):87-103</RefSource>
<PMID Version="1">25614319</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Genomics. 2013 Nov 11;14:778</RefSource>
<PMID Version="1">24215113</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Biol Chem. 2014 Feb;395(2):181-202</RefSource>
<PMID Version="1">24002663</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Med Virol. 2014 Aug;86(8):1393-401</RefSource>
<PMID Version="1">24523146</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell. 2016 Jan 28;164(3):564-78</RefSource>
<PMID Version="1">26824662</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 1998 Apr 1;160(7):3610-6</RefSource>
<PMID Version="1">9531325</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2015 Jan 15;194(2):678-89</RefSource>
<PMID Version="1">25488988</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Top Med Chem. 2015 ;15(20):2080-114</RefSource>
<PMID Version="1">25986685</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Immunol. 2008 Oct;9(10):1091-4</RefSource>
<PMID Version="1">18800157</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2014 Dec 6;384(9959):2046-52</RefSource>
<PMID Version="1">25132507</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2011 Jan 15;203(2):149-57</RefSource>
<PMID Version="1">21288813</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Biol Chem. 2014 Oct;395(10):1253-62</RefSource>
<PMID Version="1">25205732</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Vector Borne Zoonotic Dis. 2015 Apr;15(4):241-9</RefSource>
<PMID Version="1">25897810</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Small. 2010 Aug 16;6(16):1776-84</RefSource>
<PMID Version="1">20665754</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2011 Oct;7(10 ):e1002322</RefSource>
<PMID Version="1">22028657</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Virol. 1998 Feb;72(2):1516-22</RefSource>
<PMID Version="1">9445055</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Virol. 2000 Oct;74(20):9802-7</RefSource>
<PMID Version="1">11000258</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2012 Dec;122(12):4447-60</RefSource>
<PMID Version="1">23160199</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Immunology. 1991 May;73(1):117-9</RefSource>
<PMID Version="1">2045125</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Epidemiol Infect. 2012 May;140(5):842-50</RefSource>
<PMID Version="1">21767452</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arthritis Rheumatol. 2014 Feb;66(2):319-26</RefSource>
<PMID Version="1">24504804</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13950-5</RefSource>
<PMID Version="1">10570179</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Allergy Clin Immunol. 2015 Apr;135(4):846-55</RefSource>
<PMID Version="1">25843597</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Bioinformatics. 2011 Dec 17;12:480</RefSource>
<PMID Version="1">22177264</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Gen Virol. 2015 Mar;96(Pt 3):580-9</RefSource>
<PMID Version="1">25395592</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol Methods. 1991 Dec 15;145(1-2):43-53</RefSource>
<PMID Version="1">1722495</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Viral Immunol. 2010 Feb;23(1):113-7</RefSource>
<PMID Version="1">20121409</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Protoc. 2012 Mar 01;7(3):562-78</RefSource>
<PMID Version="1">22383036</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2015 Jan 15;194(2):491-7</RefSource>
<PMID Version="1">25556251</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):5974-9</RefSource>
<PMID Version="1">24711407</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):E4256-63</RefSource>
<PMID Version="1">26195744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int Rev Immunol. 2016 Sep 2;35(5):434-454</RefSource>
<PMID Version="1">26606328</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Leukoc Biol. 2013 Sep;94(3):393-8</RefSource>
<PMID Version="1">23709686</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2004 Feb 26;32(4):1372-81</RefSource>
<PMID Version="1">14988425</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell. 2015 Nov 19;163(5):1095-107</RefSource>
<PMID Version="1">26553503</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Blood. 2012 Dec 20;120(26):5237-46</RefSource>
<PMID Version="1">23149848</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Death Differ. 2011 Jul;18(7):1112-9</RefSource>
<PMID Version="1">21311565</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nucleic Acids Res. 2003 Jul 1;31(13):3576-9</RefSource>
<PMID Version="1">12824369</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nature. 2005 Apr 7;434(7034):772-7</RefSource>
<PMID Version="1">15800576</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2013 Aug 28;8(8):e72529</RefSource>
<PMID Version="1">24015257</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2011 Sep;7(9):e1002268</RefSource>
<PMID Version="1">21966274</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cell Rep. 2014 Jul 24;8(2):420-9</RefSource>
<PMID Version="1">25017060</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2007 Feb 22;356(8):769-71</RefSource>
<PMID Version="1">17314335</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arthritis Rheumatol. 2017 Feb;69(2):320-334</RefSource>
<PMID Version="1">27598995</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2008 Aug 4;205(8):1739-46</RefSource>
<PMID Version="1">18606855</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Angiogenesis. 2015 Jul;18(3):347-59</RefSource>
<PMID Version="1">26026674</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Exp Immunol. 1999 May;116(2):366-70</RefSource>
<PMID Version="1">10337032</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Gen Virol. 1986 Jun;67 ( Pt 6):1189-94</RefSource>
<PMID Version="1">3011976</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2016 Apr 21;11(4):e0153975</RefSource>
<PMID Version="1">27100888</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Immunol. 2013 Jun 15;190(12):6295-302</RefSource>
<PMID Version="1">23670192</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Invest. 2010 Mar;120(3):894-906</RefSource>
<PMID Version="1">20179353</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 2009 Sep 18;284(38):25569-75</RefSource>
<PMID Version="1">19617629</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Transplant. 2008 Mar;8(3):627-36</RefSource>
<PMID Version="1">18294159</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Genomics. 2008 Oct 16;9:488</RefSource>
<PMID Version="1">18925949</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS One. 2015 Oct 08;10(10):e0139481</RefSource>
<PMID Version="1">26447467</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2014 Dec 04;8(12):e3354</RefSource>
<PMID Version="1">25474568</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Virol. 2015 Aug;89(15):7955-69</RefSource>
<PMID Version="1">25995257</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Virol. 2012 Sep;86(18):9888-98</RefSource>
<PMID Version="1">22761364</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Infect Genet Evol. 2015 Jun;32:401-8</RefSource>
<PMID Version="1">25847693</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Infect Dis. 2008 Jun 1;197(11):1585-93</RefSource>
<PMID Version="1">18433328</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trans R Soc Trop Med Hyg. 2015 Dec;109(12):793-802</RefSource>
<PMID Version="1">26626342</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2016 Mar 03;10(3):e0004499</RefSource>
<PMID Version="1">26938618</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Blood. 2000 Feb 15;95(4):1465-72</RefSource>
<PMID Version="1">10666226</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trends Immunol. 2009 Mar;30(3):117-23</RefSource>
<PMID Version="1">19217825</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Pathog. 2008 Feb 8;4(2):e29</RefSource>
<PMID Version="1">18282093</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Exp Med. 2016 Jan 11;213(1):123-38</RefSource>
<PMID Version="1">26694968</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8112-6</RefSource>
<PMID Version="1">8058766</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Proteome Res. 2014 Dec 5;13(12):6067-77</RefSource>
<PMID Version="1">25383893</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Nat Rev Immunol. 2015 Jun;15(6):388-400</RefSource>
<PMID Version="1">25998963</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Genome Biol. 2014;15(12):550</RefSource>
<PMID Version="1">25516281</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Immunol Rev. 2008 Oct;225:27-45</RefSource>
<PMID Version="1">18837774</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001168" MajorTopicYN="N">Arthritis</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D065632" MajorTopicYN="N">Chikungunya Fever</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002646" MajorTopicYN="N">Chikungunya virus</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053804" MajorTopicYN="N">Granzymes</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008252" MajorTopicYN="N">Macaca fascicularis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>07</Month>
<Day>07</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>12</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>2</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>2</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>8</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28207896</ArticleId>
<ArticleId IdType="doi">10.1371/journal.ppat.1006155</ArticleId>
<ArticleId IdType="pii">PPATHOGENS-D-16-01536</ArticleId>
<ArticleId IdType="pmc">PMC5312928</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001138 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001138 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:28207896 |texte= RNA-Seq analysis of chikungunya virus infection and identification of granzyme A as a major promoter of arthritic inflammation. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:28207896" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
This area was generated with Dilib version V0.6.33. |